Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience

被引：0

作者：

Cellerino, Maria ^{[1
]}

Boffa, Giacomo ^{[1
]}

Lapucci, Caterina ^{[2
]}

Sbragia, Elvira ^{[1
]}

Bruschi, Nicolo ^{[1
]}

Mancuso, Elisabetta ^{[1
]}

Tazza, Francesco ^{[1
]}

Poire, Ilaria ^{[3
]}

Laroni, Alice ^{[3
]}

Capello, Elisabetta ^{[3
]}

Uccelli, Antonio ^{[1
,3
]}

Novi, Giovanni ^{[3
]}

Inglese, Matilde ^{[1
]}

机构：

[1] Univ Genoa, DINOGMI, Genoa, Italy

[2] Lab Neurosci Sperimentali, Osped Policlin San Martino IRCCS, Genoa, Italy

[3] Dept Neurol, Osped Policlin San Martino IRCCS, Genoa, Italy

来源：

NEUROLOGY | 2021年 / 96卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

2504

引用

页数：3

共 50 条

[1] Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience
Cellerino, M.
Boffa, G.
Lapucci, C.
Sbragia, E.
Bruschi, N.
Mancuso, E.
Tazza, F.
Poire, I.
Laroni, A.
Capello, E.
Uccelli, A.
Novi, G.
Inglese, M.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 295 - 295
[2] Ocrelizumab treatment in patients with relapsing-remitting multiple sclerosis: a single-center real-world experience
Lapucci, C.
Boffa, G.
Cellerino, M.
Novi, G.
Sbragia, E.
Bruschi, N.
Mancuso, E.
Tazza, F.
Laroni, A.
Capello, E.
Uccelli, A.
Inglese, M.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 177 - 178
[3] Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients
Prockl, Victoria
Nickel, Florian T.
Utz, Kathrin S.
Froehlich, Kilian
Engelhorn, Tobias
Hilz, Max-Josef
Lee, De-Hyung
Linker, Ralf A.
Huhn, Konstantin
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 415
[4] Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience
Sbragia, E.
Olobardi, D.
Giovanni, N.
Lapucci, C.
Boffa, G.
Capello, E.
Cellerino, M.
Laroni, A.
Sticchi, L.
Inglese, M.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 648 - 649
[5] Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
Sbragia, Elvira
Olobardi, Dario
Novi, Giovanni
Lapucci, Caterina
Cellerino, Maria
Boffa, Giacomo
Laroni, Alice
Mikulska, Malgorzata
Sticchi, Laura
Inglese, Matilde
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
[6] Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience
Sbragia, E.
Olobardi, D.
Novi, G.
Lapucci, C.
Cellerino, M.
Boffa, G.
Laroni, A.
Mikulska, M.
Sticchi, L.
Inglese, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 788 - 788
[7] Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience
Nasello, Martina
Zancan, Valeria
Rinaldi, Virginia
Marrone, Antonio
Renie, Roberta
Diamant, Selene
Marconi, Martina
Le Mura, Lorenzo
Salvetti, Marco
Buscarinu, Maria Chiara
Bellucci, Gianmarco
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
[8] Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis
Daniels, K.
van der Nat, P. B.
Frequin, S. T. F. M.
van der Wees, P. J.
Biesma, D. H.
Hoogervorst, E. L. J.
van de Garde, E. M. W.
MULTIPLE SCLEROSIS INTERNATIONAL, 2020, 2020
[9] Real world experience with ocrelizumab in patients with primary progressive multiple sclerosis
Lopez Ruiz, R.
Dotor Garcia-Soto, J.
Hiraldo, J. D. G.
Ruiz-Pena, J. L.
Paramo Camino, M. D.
Ruiz De Arcos, M.
Navarro Mascarell, G.
Eichau Madueno, S.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 301 - 302
[10] Two-year real-world experience with ocrelizumab in the treatment of patients with multiple sclerosis
Vollmer, B.
Ijadi, N.
Declusin, A.
Nair, K.
Sillau, S.
Corboy, J.
Vollmer, T.
Alvarez, E.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 595 - 596

← 1 2 3 4 5 →